Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award
Assist. Prof. Dr Mohamed Hassan, Tulane University School of Medicine, United States
Assist. Prof. Dr. Mohamed Hassan is a distinguished researcher in molecular biology, tumor biology, and virology ๐งฌ. His groundbreaking work focuses on tumor progression, cancer stem cell biology, and innovative therapeutic strategies ๐ฏ. With an extensive portfolio of high-impact publications ๐ and supervised doctoral candidates ๐, his research significantly contributes to understanding melanoma resistance, non-receptor tyrosine kinases, and immune checkpoint inhibitors ๐ฅ. He has collaborated with leading international institutions, enriching the field with novel discoveries in oncology ๐ฌ. His contributions extend beyond research, fostering the next generation of scientists and improving clinical oncology outcomes ๐ฅ.
Publication Profile
Education
Dr. Mohamed Hassan earned his Ph.D. in Molecular Biology ๐ from the University Hospital of Dรผsseldorf, Germany (2001), where his research focused on the interference of the Hepatitis C Virus (HCV) core protein with intracellular signal transduction in liver cells ๐ฆ . He holds an M.Sc. in Molecular Biology ๐ from the University of Dรผsseldorf (1996), with a thesis on identifying and characterizing differentially expressed cDNA libraries in Plasmodium malaria chabaudi immune mice ๐งช. His academic journey began with a B.Sc. in Biological Sciences ๐ซ from Zagazig University, Egypt, and the University of Dรผsseldorf (1983). His expertise in cancer biology, virology, and molecular research ๐ has established him as a leading researcher in the field.
Experience
Assist. Prof. Dr. Mohamed Hassan is a dedicated cancer researcher with extensive expertise in tumor progression, oncological drug resistance, and precision medicine ๐ฌ๐. He is currently a Senior Postdoctoral Fellow at the Institut National de la Santรฉ et de la Recherche Mรฉdicale, University of Strasbourg, France (2018-2025) ๐ฅ. Previously, he served as a Research Assistant Professor at Tulane University School of Medicine, USA (2016-2018) ๐, and a Postdoctoral Fellow at the University Hospital of Dรผsseldorf, Germany (2002-2004). His groundbreaking work focuses on identifying biomarkers and developing targeted therapies to enhance cancer treatment worldwide ๐๐งฌ.
Research Focus
Assist. Prof. Dr. Mohamed Hassanโs research focuses on tumor progression, cancer stem-like cells, and treatment resistance ๐งฌ. His work delves into melanomaโs resistance to standard therapies ๐ฏ, mechanisms of tumor progression and immune evasion ๐ฅ, and targeting cancer stem-like cells to enhance treatment efficacy ๐. He investigates the role of non-receptor tyrosine kinases in oncogenesis ๐ฌ and explores immune checkpoint inhibitors and their associated cutaneous adverse effects โ๏ธ. Additionally, his discovery of antimicrobial peptides holds promise for clinical applications ๐ฆ . His contributions drive novel therapeutic strategies, improving cancer treatment outcomes worldwide ๐.
Publication Top Notes